4534 — Mochida Pharmaceutical Co Income Statement
0.000.00%
Last trade - 00:00
- ¥109bn
- ¥66bn
- ¥103bn
- 54
- 55
- 39
- 47
2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
Standards: | JAS | JAS | JAS | JAS | JAS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 109,643 | 101,799 | 102,995 | 110,179 | 103,261 |
Cost of Revenue | |||||
Gross Profit | 54,166 | 51,917 | 54,792 | 59,553 | 55,115 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 98,438 | 95,983 | 91,244 | 96,515 | 94,741 |
Operating Profit | 11,205 | 5,816 | 11,751 | 13,664 | 8,520 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 11,642 | 6,273 | 11,900 | 14,591 | 9,044 |
Provision for Income Taxes | |||||
Net Income After Taxes | 8,435 | 4,598 | 8,588 | 10,569 | 6,649 |
Net Income Before Extraordinary Items | |||||
Net Income | 8,435 | 4,598 | 8,588 | 10,569 | 6,649 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 8,435 | 4,598 | 8,587 | 10,569 | 6,649 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 204 | 172 | 229 | 291 | 180 |
Dividends per Share |